EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of Serum ELMO-3 Levels with Metastatic Status and Survival Outcomes in Non-Small Cell Lung Cancer

Hilal Oğuz Soydinç iD, Murat Serilmez iD, Ceren Tilgen Yasasever iD, Elif Bilgin Doğru iD, Uğur Gezer iD, Şule Karaman, Nergiz Dağoğlu Sakin, Derya Duranyıldız

Current Issues in Molecular Biology · 21.04.2026 · 48 (4) · 427

DOI: 10.3390/cimb48040427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 21.04.2026. Verfasst von Hilal Oğuz Soydinç und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Oncology, Oncology Institute, Istanbul University, 34093 Istanbul, Türkiye. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Istanbul University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small cell lung cancer remains one of the leading causes of cancer-related mortality worldwide, and identifying molecular markers associated with tumor progression and metastasis is important for improving patient management. This study investigated serum ELMO-3 levels in patients with NSCLC and evaluated their relationship with clinicopathological characteristics. Serum samples from 50 NSCLC patients and 20 healthy controls were analyzed. ELMO-3 concentrations were measured using an enzyme-linked immunosorbent assay. Statistical analyses included non-parametric group comparisons, receiver operating characteristic curve analysis, Kaplan–Meier survival analysis, and multivariate Cox proportional hazards regression. The mean ELMO-3 level was 0.409 ± 0.543, which was used as the cutoff value to categorize patients into low- and high-ELMO-3 groups; 76% of patients were classified as low-ELMO-3 and 24% as high-ELMO-3. The results showed that serum ELMO-3 levels did not differ significantly between NSCLC patients and healthy controls and were not associated with metastatic status. However, a significant association was observed between ELMO-3 expression status and tumor histopathology. Survival analysis demonstrated that distant metastasis and radiotherapy were significantly associated with overall survival. In multivariate analysis, age, operability, distant metastasis, and serum ELMO-3 levels were identified as independent factors associated with survival. These findings suggest that circulating ELMO-3 may have potential prognostic relevance; however, the results should be interpreted with caution and require validation in larger, independent cohorts.

Schlagwörter

Stichwörter der Autor:innen

ELMO-3cell motilitymetastasisnon-small cell lung cancerprognostic factorsserum biomarker

Autor:innen und Institutionen

  • Department of Basic Oncology, Oncology Institute, Istanbul University, 34093 Istanbul, Türkiye.
  • Department of Clinic Oncology, Oncology Institute, Istanbul University, 34093 Istanbul, Türkiye.

ORCID-Profile: Hilal Oğuz Soydinç, Murat Serilmez, Ceren Tilgen Yasasever, Elif Bilgin Doğru, Uğur Gezer

Förderung

  • Istanbul University

Zitieren

APA

Oğuz Soydinç, H., Serilmez, M., Tilgen Yasasever, C., Bilgin Doğru, E., Gezer, U., Karaman, Ş., Sakin, N. D., & Duranyıldız, D. (2026). Association of Serum ELMO-3 Levels with Metastatic Status and Survival Outcomes in Non-Small Cell Lung Cancer. Current Issues in Molecular Biology, 48(4), 427. https://doi.org/10.3390/cimb48040427

Vancouver

Oğuz Soydinç H, Serilmez M, Tilgen Yasasever C, Bilgin Doğru E, Gezer U, Karaman Ş, et al. Association of Serum ELMO-3 Levels with Metastatic Status and Survival Outcomes in Non-Small Cell Lung Cancer. Current Issues in Molecular Biology. 2026;48(4):427. doi:10.3390/cimb48040427

BibTeX
@article{OuzSoydin2026,
  author = {Oğuz Soydinç, Hilal and Serilmez, Murat and Tilgen Yasasever, Ceren and Bilgin Doğru, Elif and Gezer, Uğur and Karaman, Şule and Sakin, Nergiz Dağoğlu and Duranyıldız, Derya},
  title = {Association of Serum ELMO-3 Levels with Metastatic Status and Survival Outcomes in Non-Small Cell Lung Cancer},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {4},
  pages = {427},
  doi = {10.3390/cimb48040427}
}
Kostenlos starten →